[{"Assets_0_Q1_USD":21373982.0,"CommonStockSharesOutstanding_0_Q1_shares":40668311.0,"EarningsPerShareBasic_1_Q1_USD":-0.08,"EarningsPerShareDiluted_1_Q1_USD":-0.08,"NetIncomeLoss_1_Q1_USD":-3146659.0,"StockholdersEquity_0_Q1_USD":19179036.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":38393910.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":38393910.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170207"}]